natgillin/translations-raw huggingface dataset:
However, at the lower dose, residues were above the MRLs at day 1 but below the MRLs by the second time point (day 4 after administration).
Pri manjšem odmerku pa so bili ostanki 1. dan večji od vrednosti MVO, vendar so ob drugi časovni točki (4. dan po uporabi) padli pod vrednost MVO.
The efficacy at the dosage of 2.5 mg/kg bw daily for 3 days was compared to the one of a trimetroprim-sulfamid fixed combination (30 mg/kg bw daily for 3 days).
Učinkovitost odmerjanja 2,5 mg/kg telesne mase/dan 3 dni so primerjali z eno od fiksnih kombinacij trimetoprima/sulfamida (30 mg/kg telesne mase/dan 3 dni).
8 CVMP note for guidance on the approach towards harmonisation of withdrawal periods (EMEA/CVMP/036/95)http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004428.pdf
8 CVMP note for guidance on the approach towards harmonisation of withdrawal periods (EMEA/CVMP/036/95)http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004428.pdf podatkov karence ni bilo mogoče izpeljati s statističnim pristopom.
Baytril 5%, Ενέσιμο διάλυμα για μόσχους, χοίρους και σκύλους
Baytril 5%, Ενέσιμο διάλυμα για μόσχους, χοίρους και σκύλους teleta, prašiči, psi
All residues were below the MRLs at 5 days.
Vse vrednosti ostankov so bile pod MVO po 5 dneh.
(e.g. Staphylococcus aureus) and against Mycoplasma spp.
(npr. Staphylococcus aureus), in proti bakterijam Mycoplasma spp.
aureus in commercial dairy herds was investigated.
aureus v čredah za komercialno proizvodnjo mleka.
Warning sentences have been included in sections 4.5 and 4.6 of the SPC regarding the potential articular cartilage damage in growing cattle and lambs, based on the available literature.
Na podlagi razpoložljive literature je treba v poglavji 4.5 in 4.6 povzetka glavnih značilnosti zdravila vključiti opozorilne stavke glede morebitne poškodbe hrustanca pri rastočem govedu in jagnjetih.
Supporting literature for use of enrofloxacin was provided in rodents (e.g. hamsters, gerbils, guinea pigs), in reptiles (snakes, lizards and chelonia) and in ornamental birds.
Literatura, ki podpira uporabo enrofloksacina, je bila predložena za glodavce (npr. hrčke, skakače, morske prašičke), plazilce (kače, kuščarje in želve) ter okrasne ptice.
The second dose may be administered by the subcutaneous route.
Drugi odmerek se lahko da subkutano.
Due to the variability of the data the statistical method was not considered appropriate and a withdrawal period was derived using the alternative approach.
Zaradi variabilnosti podatkov statistična metoda ni bila primerna, zato so karenco izpeljali z uporabo alternativnega pristopa.
The product can be administered by slow intravenous or subcutaneous administration.
Zdravilo se lahko daje s počasnim intravenskim ali subkutanim injiciranjem.
Data on resistance to enrofloxacin in target pathogens have been provided for cattle, pigs, sheep, goats, dogs and cats.
Podatki o odpornosti ciljnih patogenov proti enrofloksacinu so bili predloženi za govedo, prašiče, ovce, koze, pse in mačke.
Only few data have been submitted by the MAHs regarding resistance in food borne bacteria.
Imetniki dovoljenj za promet z zdravilom so predložili samo nekaj podatkov o odpornosti pri bakterijah, ki se prenašajo s hrano.
Dogs, cats, exotic animals
psi, mačke, eksotične živali
Low to moderate (8% to 20%) resistance rates to ciprofloxacin have been observed in indicator isolates of E. coli for the different target species in different European countries.
Pri indikatorskih izolatih E. coli za različne ciljne živalske vrste v različnih evropskih državah so opazili majhno do zmerno (8- do 20-odstotno) stopnjo odpornost proti ciprofloksacinu.
Bayer Animal Health GmbH Kaiser-Wilhelm-Allee 50 51368 Leverkusen Germany
Bayer Animal Health GmbH Kaiser-Wilhelm-Allee 50 51368 Leverkusen Nemčija
In view of the lack of therapeutic alternatives, if this indication was not accepted, this product as well as many other antimicrobial products, could be used off-label (under the so-called cascade).
Če ta indikacija ne bi bila sprejeta, bi se zaradi pomanjkanja drugih oblik zdravljenja to zdravilo in mnogi drugi antibiotiki uporabljali neskladno z informacijami o zdravilu.
Rodents, reptiles and ornamental birds (25 mg/ml strength) Treatment of infections of the alimentary and respiratory tracts where clinical experience, if possible supported by sensitive testing of the causal organism, indicates enrofloxacin as the substance of choice.
Glodavci, plazilci in okrasne ptice (jakost 25 mg/ml) Zdravljenje okužb prebavil in dihal, kadar klinične izkušnje, po možnosti podprte s preskusi občutljivosti povzročiteljev, kažejo, da je enrofloksacin priporočena učinkovina.
In conclusion the Committee can accept this indication considering that it is an injectable formulation, and that necessary restrictions provided in the SPC, together with the withdrawal period, would be in favour of a more adequate use of the veterinary medicinal product in rabbits compared to the use under the cascade.
Odbor lahko torej sprejme to indikacijo za formulacijo za injiciranje, če bi bile potrebne omejitve v povzetku glavnih značilnosti zdravila skupaj s karenco v korist primernejši uporabi zdravila za uporabo v veterinarski medicini pri kuncih v primerjavi z uporabo, neskladno z informacijami o zdravilu.
Rabbits are classified as minor species and thus the available data is assessed in the context of the CVMP guideline on efficacy and target animal safety data requirements for veterinary medicinal products intended for minor uses or minor species (EMEA/CVMP/EWP/117899/2004).
Kunci so razvrščeni kot manj pomembna živalska vrsta, zato se razpoložljivi podatki ocenjujejo v sklopu smernice CVMP o zahtevah za podatke o učinkovitosti in varnosti ciljnih živalskih vrst za zdravila za uporabo v veterinarski medicini, namenjena manj pomembni uporabi ali manj pomembnim vrstam (EMEA/CVMP/EWP/117899/2004).
Sheep intended for milk production and goats do not fall into the category of major species, are by default are classified as minor species and, thus, assessed in the context of the CVMP guideline on efficacy and target animal safety data requirements for veterinary medicinal products intended for minor uses or minor species (EMEA/CVMP/EWP/117899/2004)2.
Ovce, namenjene proizvodnji mleka, in koze ne spadajo v kategorijo pomembnejših živalskih vrst, zato so privzeto razvrščene kot manj pomembne živalske vrste in se posledično ocenjujejo v sklopu smernice CVMP o zahtevah za podatke o učinkovitosti in varnosti ciljnih živalskih vrst za zdravila za uporabo v veterinarski medicini, namenjena manj pomembni uporabi ali manj pomembnim vrstam (EMEA/CVMP/EWP/117899/2004)2.
In another study piglets were challenged with E. coli and displayed signs of diarrhoea and enterotoxaemia.
V drugi študiji so pri pujskih opravili provokacijski test z E. coli, pri čemer so se pojavili znaki driske in enterotoksemije.
Taking into account all data available (clinical, PK/PD and antimicrobial resistance data), the CVMP considered that this indication can be accepted.
Upoštevajoč vse razpoložljive podatke (klinične, FK/FD in o antimikrobni odpornosti) je odbor CVMP menil, da je ta indikacija sprejemljiva.
Treatment of infections of the alimentary tract and septicaemia caused by enrofloxacin susceptible strains of Escherichia coli (50 mg/ml and 100 mg/ml strengths)
Zdravljenje okužb prebavil in septikemije, ki jih povzročajo za enrofloksacin občutljivi sevi bakterije Escherichia coli (jakosti 50 mg/ml in 100 mg/ml)
In the field study, calves (from 15 kg to 150 kg bw) with naturally occurring gastrointestinal infections due to E.coli, were treated every day with enrofloxacin either orally, by a parenteral (intramuscular, subcutaneous or intravenous) route followed by oral, or only parenteral route.
V terenski študiji so teleta (od 15 do 150 kg telesne mase) z naravnimi okužbami prebavil z E. coli vsak dan zdravili s peroralnim, parenteralnim (intramuskularnim, subkutanim ali intravenskim) enrofloksacinom, ki mu je sledil peroralni enrofloksacin, ali samo s parenteralnim enrofloksacinom.
Antimicrobial resistance in food borne bacteria
Protimikrobna odpornost pri bakterijah, ki se prenašajo s hrano
Arthritis caused by Mycoplasma bovis (50 mg/ml and 100 mg/ml strengths)
Artritis, ki ga povzroča Mycoplasma bovis (jakosti 50 mg/ml in 100 mg/ml)
Cattle, pigs weighing more than 25 kg
govedo, prašiči s telesno maso več kot 25 kg
Acute severe mastitis caused by Escherichia coli (100 mg/ml strength)
Hudi akutni mastitis, ki ga povzroča Escherichia coli (jakost 100 mg/ml)
In the second study, lambs with septicaemia caused by E. coli and Cl. perfringens were treated intramuscularly at the dosage of 5 mg/kg bw for 5 days.
V drugi študiji so jagnjeta s septikemijo, ki jo povzročata E. coli in Cl. perfringens, zdravili z intramuskularnim odmerkom 5 mg/kg telesne mase 5 dni.
Results of a dose-titration study with experimentally induced infection with enterotoxigenic E. coli in suckling piglets and weaners were also reported.
Poročali so tudi o rezultatih študije za titracijo odmerka pri eksperimentalno sproženi okužbi z enterotoksigeno E. coli pri sesnih in odstavljenih pujskih.
• on the basis of the available data, the CVMP considered that the dose rate of 2.5 mg/kg bw/day should be deleted for all the indications in cattle.
• odbor CVMP je menil, da je treba na podlagi razpoložljivih podatkov odmerjanje 2,5 mg/kg telesne mase/dan izbrisati pri vseh indikacijah za govedo;
Taking into account all (clinical, PK/PD and antimicrobial resistance) data, the CVMP considered that this indication can be accepted.
Upoštevajoč vse podatke (klinične, FK/FD in o antimikrobni odpornosti) je odbor CVMP menil, da je ta indikacija sprejemljiva.
However, several experimental controlled studies were conducted employing both 2.5 and 5 mg/kg body weight (bw) parenteral doses, but more consistent data on the higher dose were presented.
2,5 in 5 mg/kg telesne mase, vendar so bili predloženi doslednejši podatki za večji odmerek.
Two different doses were examined: 2.5 mg/kg bw and 5 mg/kg bw, twice daily for 3 consecutive days.
Raziskali so dva različna odmerka: 2,5 mg/kg telesne mase in 5 mg/kg telesne mase, dvakrat na dan, 3 zaporedne dneve.
08028 Barcelona Spain
08028 Barcelona Španija
Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable and associated names, and related veterinary medicinal products authorised under Article 13 of Directive 2001/82/EC, as amended are solutions for injection containing enrofloxacin at 25 mg/ml, 50 mg/ml and 100 mg/ml respectively.
Zdravila Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable in povezana imena ter z njimi povezana zdravila za uporabo v veterinarski medicini, odobrena skladno s členom 13 Direktive 2001/82/ES, kot je bila spremenjena, so raztopine za injiciranje, ki vsebujejo 25 mg/ml, 50 mg/ml oziroma 100 mg/ml enrofloksacina.
Following intravenous injection: Meat and offal: 5 days.
Po intravenskem injiciranju: meso in organi: 5 dni.
On 22 April 2013, Spain presented to the European Medicines Agency (the Agency) a referral notification under Article 35 of Directive 2001/82/EC for Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable and associated names, and related veterinary medicinal products authorised under Article 13 of Directive 2001/82/EC, as amended.
Španija je 22. aprila 2013 Evropski agenciji za zdravila (v nadaljevanju: agencija) predložila obvestilo o napotitvi v skladu s členom 35 Direktive 2001/82/ES za zdravila Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable in povezana imena ter z njimi povezana zdravila za uporabo v veterinarski medicini, odobrena skladno s členom 13 Direktive 2001/82/ES, kot je bila spremenjena.
It was considered appropriate to derive a single withdrawal period based on the combined data from these 2 studies using the alternative approach.
Odbor je menil, da je primerno, da se na podlagi združenih podatkov iz teh 2 študij z alternativnim pristopom izpelje ena karenca.
All animals were treated intramuscularly with enrofloxacin at 2.5 mg/kg bw once daily.
Vse živali so intramuskularno zdravili z enrofloksacinom v odmerku 2,5 mg/kg telesne mase enkrat na dan.
• on the basis of the available residue depletion data in cattle, pigs, sheep, goats and rabbits chickens and turkeys, the CVMP considered that withdrawal periods should be aligned to provide assurance for consumer safety;
• odbor CVMP je menil, da je treba na podlagi razpoložljivih podatkov o izločanju ostankov pri govedu, prašičih, ovcah, kozah, kuncih, piščancih in puranih uskladiti karence, tako da bodo zagotavljale varnost potrošnikov;
Austria aniMedica GmbH Im Südfeld 9
Avstrija aniMedica GmbH Im Südfeld 9
A field study was conducted to evaluate effect of enrofloxacin against pathogens related to the alimentary tract in suckling and weaning piglets with diarrhoea.
Opravili so terensko študijo za ocenjevanje učinka enrofloksacina proti patogenom, povezanim s prebavili pri sesnih in odstavljenih pujskih z drisko.
The available data does fully demonstrate the efficacy of this veterinary medicinal product for the treatment of septicaemia.
Učinkovitost tega zdravila za uporabo v veterinarski medicini pri zdravljenju septikemije je bila popolnoma dokazana na podlagi razpoložljivih podatkov.
Rodents, reptiles and ornamental birds
Glodavci, plazilci in okrasne ptice
The use of enrofloxacin in growing lambs at the recommended dose for 15 days caused histological changes in the articular cartilage, not associated with clinical signs.
Uporaba enrofloksacina pri rastočih jagnjetih, ki so jih 15 dni zdravili s priporočenim odmerkom, je povzročila histološke spremembe sklepnega hrustanca, ki niso bile povezane s kliničnimi znaki.
Treatment of infections of the alimentary and respiratory tracts where clinical experience, if possible, supported by susceptibility testing of the causal organism, indicates enrofloxacin as the substance of choice.
Zdravljenje okužb prebavil in dihal, kadar klinične izkušnje, po možnosti podprte s preskusi občutljivosti povzročiteljev, kažejo, da je enrofloksacin priporočena učinkovina.
PK/PD and antimicrobial resistance data have been taken into account to justify this indication.
Za utemeljitev te indikacije so bili upoštevani FK/FD podatki in podatki o antimikrobni odpornosti.
At the recommended dose residues in all tissues were below the MRLs at day 1 postadministration.
Pri priporočenem odmerku so bili ostanki v vseh tkivih 1 dan po uporabi pod mejno vrednostjo ostankov (MVO).
The documentation provided was considered acceptable to support the efficacy of enrofloxacin against infections of the alimentary and respiratory tracts caused by Escherichia coli, Pasteurella multocida and Staphylococcus spp.
Odbor je menil, da je bila predložena dokumentacija sprejemljiva za podporo učinkovitosti enrofloksacina proti okužbam prebavil in dihal, ki jih povzročajo Escherichia coli, Pasteurella multocida in Staphylococcus spp.
Enrofloksacyna 10 % inj., 100 mg/ml roztwór do wstrzykiwań dla bydła
Enrofloksacyna 10 % inj., 100 mg/ml roztwór do wstrzykiwań dla bydła govedo
This withdrawal period should be applied to all the concerned products.
Ta karenca mora veljati za vsa zadevna zdravila.
Cattle, pigs weighing more than 25 kg, dogs, cats
govedo, prašiči s telesno maso več kot 25 kg, psi, mačke
Roxacin injection
Roxacin injection prašiči
Grounds for amendment of the summaries of product characteristics, labelling and package leaflets
Razlogi za spremembo povzetkov glavnih značilnosti zdravila, označevanja in navodil za uporabo
Nevertheless, taking into account the available PK/PD and resistance data it has been concluded that the dose for this indication can be accepted only at 5 mg of enrofloxacin per kg bw once daily for 3 days by intramuscular injection.
Vendar je odbor na podlagi razpoložljivih FK/FD podatkov in podatkov o odpornosti sklenil, da je za to indikacijo mogoče sprejeti samo odmerek enrofloksacina 5 mg na kg telesne mase enkrat na dan 3 dni, ki se daje z intramuskularnim injiciranjem.
Baytril 2,5% inj., 25 mg/ml roztwór do wstrzykiwań dla psów i kotów
Baytril 2,5% inj., 25 mg/ml roztwór do wstrzykiwań dla psów i kotów psi, mačke
Where the following target species have already been approved, the following withdrawal periods apply:
Če so bile spodaj navedene ciljne živalske vrste že odobrene, veljajo naslednje karence:
Pigs, cattle
prašiči, govedo
As stated in CVMP reflection paper on the use of fluoroquinolones in food producing animalsPrecautions for use in the SPC regarding prudent use guidance6, fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials.
preudarni uporabi6, je treba uporabo fluorokinolonov omejiti na zdravljenje kliničnih stanj, ki se slabo odzivajo ali za katere je pričakovati, da se bodo slabo odzivala na druge razrede antibiotikov.
Laboratorios Syva S.A. Parroco Pablo Diez, 49 - 57 24010 Leon
Bolgarija Laboratorios Syva S.A. Parroco Pablo Diez, 49 - 57 24010 Leon
Three different doses of enrofloxacin were administered: 1.25, 2.5 or 5 mg/kg bw/day for 3 days.
Uporabili so tri različne odmerke enrofloksacina: 1,25, 2,5 ali 5 mg/kg telesne mase/dan 3 dni.
(e.g. Pasteurella multocida), against Gram-positive bacteria such as Staphylococcus spp.
(npr. Pasteurella multocida), proti grampozitivnim bakterijam, kot so na primer Staphylococcus spp.
In order to compensate for the biological uncertainties and the variability of the data, a safety span of 30% was used, resulting in a withdrawal period of 12 days.
Odbor je menil, da je za kompenzacijo za biološke negotovosti in variabilnost podatkov, ustrezen 30odstotni varnostni razpon, kar pomeni karenco 12 dni.
Milk (100 mg/ml strength):
Mleko (jakost 100 mg/ml):
Overall summary of the scientific evaluation of Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable and associated names, and related veterinary medicinal products authorised under Article 13 of Directive 2001/82/EC, as amended (see Annex I)
Splošni povzetek znanstvenega vrednotenja zdravil Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable in povezanih imen ter z njimi povezanih zdravil za uporabo v veterinarski medicini, odobrenih skladno s členom 13 Direktive 2001/82/ES, kot je bila spremenjena (glejte Prilogo I)
Meat and offal (25 mg/ml strength): Two residue depletion studies were provided, but only in one of the studies were the animals treated at the recommended dose of 10 mg/kg bw for up to 10 days.
Meso in organi (jakost 25 mg/ml): Predloženi sta bili dve študiji izločanja ostankov, vendar so samo v eni študiji živali zdravili s priporočenim odmerkom 10 mg/kg telesne mase do 10 dni.
In order to compensate for the biological uncertainties and the variability of the data, a safety span of 30% was used, resulting in a withdrawal period of 13 days.
Odbor je menil, da je za kompenzacijo za biološke negotovosti in variabilnost podatkov ustrezen 30odstotni varnostni razpon, kar pomeni karenco 13 dni.
A. For products listed in Annex I containing 25 mg enrofloxacin per ml
A. Za zdravila, navedena v Prilogi I, ki vsebujejo 25 mg enrofloksacina na ml
Care should be taken during the concomitant use of flunixin and enrofloxacin in dogs to avoid adverse drug reactions.
Pri sočasni uporabi fluniksina in enrofloksacina pri psih je potrebna previdnost, da se prepreči neželene učinke zdravila.
In this case, the withdrawal period following subcutaneous injection applies.
V tem primeru je treba upoštevati karenco po subkutanem injiciranju.
Meat and offal (50 mg/ml and 100 mg/ml strengths): Data were available from two studies, one performed with a dose of 2.5 mg/kg bw/day for 5 days and one with a dose of 5 mg/kg bw/day for 5 days.
Meso in organi (jakosti 50 mg/ml in 100 mg/ml): Na voljo so bili podatki iz dveh študij; ena je bila izvedena z odmerkom 2,5 mg/kg telesne mase/dan 5 dni, druga pa z odmerkom 5 mg/kg telesne mase/dan 5 dni.
and Histophilus somni (50 mg/ml and 100 mg/ml strengths)
in Histophilus somni (jakosti 50 mg/ml in 100 mg/ml)
It was considered appropriate to derive a single harmonised withdrawal period based on the combined data from the 4 studies.
Odbor je menil, da je primerno, da se na podlagi združenih podatkov iz 4 študij izpelje ena usklajena karenca.
Baytril Piglet 25 mg/ml inspuitbare oplossing
Baytril Piglet 25 mg/ml inspuitbare oplossing prašiči
C. For products listed in Annex I containing 100 mg enrofloxacin per ml
C. Za zdravila, navedena v Prilogi I, ki vsebujejo 100 mg enrofloksacina na ml
It has been noted that the indications, posology and withdrawal periods approved by the Member States for Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable and associated names, and related veterinary medicinal products authorised under Article 13 of Directive 2001/82/EC are disharmonised across the Member States (EU/EEA).
Ugotovili so, da indikacije, odmerjanje in karence, odobrene v državah članicah za zdravila Baytril 2.5% injectable, Baytril 5% injectable, Baytril 10% injectable in povezana imena ter z njimi povezana zdravila za uporabo v veterinarski medicini, odobrena skladno s členom 13 Direktive 2001/82/ES, v državah članicah (EU/EGS) niso usklajene.
Agnoletti et al. First reporting of methicillin-resistant Staphylococcus aureus (MRSA) ST398 in an industrial rabbit holding and in farm-related people.
Rev Sci Tech Off Int Epiz 2009;28:1119-1128 5 Agnoletti et al. First reporting of methicillin-resistant Staphylococcus aureus (MRSA) ST398 in an industrial rabbit holding and in farm-related people.
Baytril - Das Original - 2,5% Injektionslösung für Hunde, Katzen, Schweine und Kaninchen
Baytril - Das Original - 2,5% Injektionslösung für Hunde, Katzen, Schweine und Kaninchen prašiči, kunci, psi, mačke
Meat and offal (25 mg/ml, 50 mg/ml and 100 mg/ml strengths): Four studies were considered adequate for use in deriving the withdrawal period: one complete study performed with the recommended dose and three limited studies focused on the injection site, which was the withdrawal period determining tissue.
Meso in organi (jakosti 25 mg/ml, 50 mg/ml in 100 mg/ml): Za uporabo pri izpeljavi karence so bile primerne štiri študije: ena popolna študija, izvedena s priporočenim odmerkom, in tri omejene študije, ki so se osredotočile na mesto injiciranja, ki je bilo tkivo za določanje karence.
Pigs (piglets)
Prašiči (pujski)
Pigs: Meat and offal: 13 days.
Prašiči: Meso in organi: 13 dni.
Two field studies were provided to demonstrate the efficacy of enrofloxacin in the treatment of infections of the alimentary tract caused by E.coli and septicaemia caused by E.coli.
Za dokazovanje učinkovitosti enrofloksacina pri zdravljenju okužb prebavil in septikemije, ki ju povzroča E. coli, sta bili predloženi dve terenski študiji.
Taking into account all data, the CVMP considered that both indications can be accepted.
Upoštevajoč vse podatke je odbor CVMP menil, da sta sprejemljivi obe indikaciji.
Treatment of post-partum dysgalactiae syndrome (PDS), mastitis, metritis, agalactia (MMA syndrome) caused by enrofloxacin susceptible strains of Escherichia coli, Klebsiella spp.
Zdravljenje poporodnega sindroma disgalaktije (post-partum dysgalactiae syndrome - PDS), mastitisa, metritisa, agalaktije (sindrom MMA), ki ga povzročajo za enrofloksacin občutljivi sevi bakterij Escherichia coli in Klebsiella spp.
Baytril piglet 25mg/ml
Baytril piglet 25mg/ml prašiči
Following subcutaneous injection: Meat and offal: 12 days.
Po subkutanem injiciranju: Meso in organi: 12 dni.
Taking into account all the documentation provided, the CVMP considered that this indication can be accepted, but in the 50 mg/ml strength it should be stated as “Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of
menil, da je ta indikacija sprejemljiva, vendar je treba pri jakosti 50 mg/ml navesti »Zdravljenje akutnega, z mikoplazmo povezanega artritisa, ki ga povzročajo za enrofloksacin občutljivi sevi Mycoplasma bovis«.
Dogs, cats
psi, mačke
CENAVISA SA LABORATORIOS Cami Pedra Estela s/n 43205 REUS
Romunija CENAVISA SA LABORATORIOS Cami Pedra Estela s/n